‌

US Patent 9850247 Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors

Patent 9850247 was granted and assigned to Almac on December, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Almac Discovery Limited

Current Assignee

Almac

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9850247

Date of Patent

December 26, 2017

Patent Application Number

15105869

Date Filed

December 19, 2014

Patent Primary Examiner

‌

Jeffrey H Murray

Patent abstract

The present invention relates to compounds that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer.